Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
Status:
Withdrawn
Trial end date:
1999-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in
patients who have familial adenomatous polyposis.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in
preventing the development and growth of polyps in patients who have familial adenomatous
polyposis.